Mr Gajanan Patil, COO, H&H Healthcare and Cosmetics
In this video:
Mr Gajanan Patil, COO, H&H Healthcare and Cosmetics
Topic: CDMO opportunity: India’s next manufacturing advantage
Key Takeaways:
[1] The global pharma industry is shifting from traditional manufacturing to strategic CDMO partnerships driven by cost, speed, innovation and supply chain resilience.
[2] India is positioned to lead the next wave of CDMO growth through cost competitiveness, scientific talent, regulatory credibility and the China+One opportunity.
[3] Indore–Pithampur has the infrastructure, export ecosystem, talent base and logistics advantage to emerge as a major global pharma CDMO hub.
The post Mr Gajanan Patil, COO, H&H Healthcare and Cosmetics appeared first on Express Pharma.
Apa Reaksi Anda?
Suka
0
Kurang Suka
0
Setuju
0
Tidak Setuju
0
Bagus
0
Berguna
0
Hebat
0
Edusehat
Platform Edukasi Online Untuk Komunitas Kesehatan Agar Mendapatkan Informasi Dan Pengetahuan Terbaru Tentang Kesehatan Dari Nasional Maupun Internasional. ||
An online education platform for the health community to obtain the latest information and knowledge about health from both national and international sources.
